These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11770262)

  • 1. [Infectious diseases as a weapon: vigilance is needed].
    Kingma JH; van Wijngaarden JK
    Ned Tijdschr Geneeskd; 2001 Dec; 145(49):2364-5. PubMed ID: 11770262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communicable-disease surveillance in New Jersey.
    Bednarczyk M; Lu S; Tan CG; Bresnitz EA
    N J Med; 2004 Sep; 101(9 Suppl):45-50; quiz 50-2. PubMed ID: 15497734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance indicators for response to selected infectious disease outbreaks: a review of the published record.
    Potter MA; Sweeney P; Iuliano AD; Allswede MP
    J Public Health Manag Pract; 2007; 13(5):510-8. PubMed ID: 17762697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notification - what's it all about?
    Esler D; Just E
    Aust Fam Physician; 2007 May; 36(5):337-9. PubMed ID: 17492068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Update on biological weapons and bioterrorism. Important that health services pay attention to unusual events].
    Roffey R; Lantorp K; Tegnell A; Elgh F
    Lakartidningen; 2001 Dec; 98(50):5746-8, 5751-2. PubMed ID: 11789096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?
    Mayer TA; Morrison A; Bersoff-Matcha S; Druckenbrod G; Murphy C; Howell J; Hanfling D; Cates R; Pauze D; Earls J
    Clin Infect Dis; 2003 May; 36(10):1275-83. PubMed ID: 12746773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines to implement medical examiner/coroner-based surveillance for fatal infectious diseases and bioterrorism ("Med-X").
    Nolte KB; Fischer M; Reagan S; Lynfield R;
    Am J Forensic Med Pathol; 2010 Dec; 31(4):308-12. PubMed ID: 20683243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicine. The bioterrorist threat and access to health care.
    Wynia MK; Gostin L
    Science; 2002 May; 296(5573):1613. PubMed ID: 12040164
    [No Abstract]   [Full Text] [Related]  

  • 9. [More and faster notification of infectious disease if notification is carried out by the laboratories instead of the diagnosing physician].
    Rietveld A; Schneeberger PM; Wijkmans CJ
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):304-7. PubMed ID: 15730039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Our first line of defense against bioterrorism part 2.
    Simpson RL
    Nurs Manage; 2002 May; 33(5):10, 11. PubMed ID: 12006878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence of a mild form of inhalational Bacillus anthracis infection during a bioterrorism-related inhalational anthrax outbreak in Washington, D.C., in 2001.
    Baggett HC; Rhodes JC; Fridkin SK; Quinn CP; Hageman JC; Friedman CR; Dykewicz CA; Semenova VA; Romero-Steiner S; Elie CM; Jernigan JA
    Clin Infect Dis; 2005 Oct; 41(7):991-7. PubMed ID: 16142664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioterrorism update--information for the dentist.
    Boylan RJ; Psoter WJ; Weiserbs KF; Glotzer DL
    Gen Dent; 2008; 56(6):520-5. PubMed ID: 18810910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bichat guidelines for the clinical management of anthrax and bioterrorism-related anthrax.
    Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G;
    Euro Surveill; 2004 Dec; 9(12):E3-4. PubMed ID: 15677848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anthrax--the Swedish perspective].
    Tegnell A; Hellers M; Wollin R; Eriksson U; Forsman M; Engstrand L; Elgh F
    Lakartidningen; 2001 Dec; 98(50):5742-5. PubMed ID: 11789095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anthrax due to deliberate infection].
    van Dissel JT; Kullberg BJ; van den Berg PC; van Steenbergen JE
    Ned Tijdschr Geneeskd; 2001 Dec; 145(49):2366-71. PubMed ID: 11770263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confronting bioterrorism: physicians on the front line.
    Varkey P; Poland GA; Cockerill FR; Smith TF; Hagen PT
    Mayo Clin Proc; 2002 Jul; 77(7):661-72. PubMed ID: 12108604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anthrax as a bioweapon].
    Szafraniec S; Grzesiowski P; Hryniewicz W
    Przegl Lek; 2004; 61(3):177-80. PubMed ID: 15518328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the front lines: family physicians' preparedness for bioterrorism.
    Chen FM; Hickner J; Fink KS; Galliher JM; Burstin H
    J Fam Pract; 2002 Sep; 51(9):745-50. PubMed ID: 12366891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of inhalational anthrax in the U.S. outbreak.
    Brookmeyer R; Blades N
    Science; 2002 Mar; 295(5561):1861. PubMed ID: 11884746
    [No Abstract]   [Full Text] [Related]  

  • 20. [The strategic plan for preparedness and response to bioterrorism in Korea].
    Hwang HS
    J Prev Med Public Health; 2008 Jul; 41(4):209-13. PubMed ID: 18664725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.